The NDAA is the primary legislative vehicle by which Congress can act to en...
2021-06-22 2 ENGLISH REPORTS
Ending the COVID-19 pandemic through global cooperation is our first priority. We promote equitable and affordable access and delivery of safe and effective COVID-19 vaccines, diagnostics, and therapeutics through the Access to COVID-19 Tools Accelerator. We commit to continuing to support the COVAX Facility and encourage more donors to make 2 billion vaccine doses available worldwide by late 2021.
We aspire to vaccinate at least two thirds of the world’s population by the end of 2022. 5. A Joint EU–US COVID Manufacturing and Supply Chain Taskforce has been established to deepen cooperation and identify and resolve issues around expanding vaccine and therapeutics production capacity, including by building new production facilities, maintaining open and secure supply chains, avoiding any unnecessary export restrictions, and encouraging voluntary sharing of knowhow and technology on mutually-determined terms including through the ACT-A.
We are committed to strengthen global health security, pandemic preparedness, and response to health emergencies and future outbreaks. We plan to leverage our strengths to help countries build the capacities to prevent, detect, and respond to infectious disease threats. We intend to work together with like-minded countries this year to explore options towards sustainable global health and health security financing, supported by strengthened global accountability, tracking and allocation of global health security financing, including the IPPPR recommendation toward a Global Health Threats Council.
标签： ENGLISH REPORTS